1 Market Overview
1.1 Drug–Device Combination Products Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug–Device Combination Products Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Infusion Pumps
1.2.3 Orthopedic Combination Products
1.2.4 Photodynamic Therapy Devices
1.2.5 Transdermal Patches
1.2.6 Drug Eluting Stents
1.2.7 Wound Care Products
1.2.8 Inhalers
1.2.9 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug–Device Combination Products Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drug–Device Combination Products Market Size & Forecast
1.4.1 Global Drug–Device Combination Products Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug–Device Combination Products Sales in Volume (2017-2028)
1.4.3 Global Drug–Device Combination Products Price (2017-2028)
1.5 Global Drug–Device Combination Products Production Capacity Analysis
1.5.1 Global Drug–Device Combination Products Total Production Capacity (2017-2028)
1.5.2 Global Drug–Device Combination Products Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug–Device Combination Products Market Drivers
1.6.2 Drug–Device Combination Products Market Restraints
1.6.3 Drug–Device Combination Products Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Drug–Device Combination Products Product and Services
2.1.4 Abbott Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Terumo Corporation
2.2.1 Terumo Corporation Details
2.2.2 Terumo Corporation Major Business
2.2.3 Terumo Corporation Drug–Device Combination Products Product and Services
2.2.4 Terumo Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Stryker Corporation
2.3.1 Stryker Corporation Details
2.3.2 Stryker Corporation Major Business
2.3.3 Stryker Corporation Drug–Device Combination Products Product and Services
2.3.4 Stryker Corporation Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Drug–Device Combination Products Product and Services
2.4.4 Mylan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business
2.5.3 Medtronic Drug–Device Combination Products Product and Services
2.5.4 Medtronic Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Allergan
2.6.1 Allergan Details
2.6.2 Allergan Major Business
2.6.3 Allergan Drug–Device Combination Products Product and Services
2.6.4 Allergan Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boston Scientific
2.7.1 Boston Scientific Details
2.7.2 Boston Scientific Major Business
2.7.3 Boston Scientific Drug–Device Combination Products Product and Services
2.7.4 Boston Scientific Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Drug–Device Combination Products Product and Services
2.8.4 Novartis Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 BD
2.9.1 BD Details
2.9.2 BD Major Business
2.9.3 BD Drug–Device Combination Products Product and Services
2.9.4 BD Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teleflex Incorporated
2.10.1 Teleflex Incorporated Details
2.10.2 Teleflex Incorporated Major Business
2.10.3 Teleflex Incorporated Drug–Device Combination Products Product and Services
2.10.4 Teleflex Incorporated Drug–Device Combination Products Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug–Device Combination Products Breakdown Data by Manufacturer
3.1 Global Drug–Device Combination Products Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug–Device Combination Products Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug–Device Combination Products
3.4 Market Concentration Rate
3.4.1 Top 3 Drug–Device Combination Products Manufacturer Market Share in 2021
3.4.2 Top 6 Drug–Device Combination Products Manufacturer Market Share in 2021
3.5 Global Drug–Device Combination Products Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug–Device Combination Products Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug–Device Combination Products Market Size by Region
4.1.1 Global Drug–Device Combination Products Sales in Volume by Region (2017-2028)
4.1.2 Global Drug–Device Combination Products Revenue by Region (2017-2028)
4.2 North America Drug–Device Combination Products Revenue (2017-2028)
4.3 Europe Drug–Device Combination Products Revenue (2017-2028)
4.4 Asia-Pacific Drug–Device Combination Products Revenue (2017-2028)
4.5 South America Drug–Device Combination Products Revenue (2017-2028)
4.6 Middle East and Africa Drug–Device Combination Products Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drug–Device Combination Products Sales in Volume by Type (2017-2028)
5.2 Global Drug–Device Combination Products Revenue by Type (2017-2028)
5.3 Global Drug–Device Combination Products Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drug–Device Combination Products Sales in Volume by Application (2017-2028)
6.2 Global Drug–Device Combination Products Revenue by Application (2017-2028)
6.3 Global Drug–Device Combination Products Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drug–Device Combination Products Sales by Type (2017-2028)
7.2 North America Drug–Device Combination Products Sales by Application (2017-2028)
7.3 North America Drug–Device Combination Products Market Size by Country
7.3.1 North America Drug–Device Combination Products Sales in Volume by Country (2017-2028)
7.3.2 North America Drug–Device Combination Products Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug–Device Combination Products Sales by Type (2017-2028)
8.2 Europe Drug–Device Combination Products Sales by Application (2017-2028)
8.3 Europe Drug–Device Combination Products Market Size by Country
8.3.1 Europe Drug–Device Combination Products Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug–Device Combination Products Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug–Device Combination Products Sales by Type (2017-2028)
9.2 Asia-Pacific Drug–Device Combination Products Sales by Application (2017-2028)
9.3 Asia-Pacific Drug–Device Combination Products Market Size by Region
9.3.1 Asia-Pacific Drug–Device Combination Products Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug–Device Combination Products Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drug–Device Combination Products Sales by Type (2017-2028)
10.2 South America Drug–Device Combination Products Sales by Application (2017-2028)
10.3 South America Drug–Device Combination Products Market Size by Country
10.3.1 South America Drug–Device Combination Products Sales in Volume by Country (2017-2028)
10.3.2 South America Drug–Device Combination Products Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug–Device Combination Products Sales by Type (2017-2028)
11.2 Middle East & Africa Drug–Device Combination Products Sales by Application (2017-2028)
11.3 Middle East & Africa Drug–Device Combination Products Market Size by Country
11.3.1 Middle East & Africa Drug–Device Combination Products Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug–Device Combination Products Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drug–Device Combination Products and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug–Device Combination Products
12.3 Drug–Device Combination Products Production Process
12.4 Drug–Device Combination Products Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug–Device Combination Products Typical Distributors
13.3 Drug–Device Combination Products Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drug–Device Combination Products Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug–Device Combination Products Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Drug–Device Combination Products Product and Services
Table 6. Abbott Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Terumo Corporation Major Business
Table 9. Terumo Corporation Drug–Device Combination Products Product and Services
Table 10. Terumo Corporation Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 12. Stryker Corporation Major Business
Table 13. Stryker Corporation Drug–Device Combination Products Product and Services
Table 14. Stryker Corporation Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Mylan Basic Information, Manufacturing Base and Competitors
Table 16. Mylan Major Business
Table 17. Mylan Drug–Device Combination Products Product and Services
Table 18. Mylan Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Medtronic Basic Information, Manufacturing Base and Competitors
Table 20. Medtronic Major Business
Table 21. Medtronic Drug–Device Combination Products Product and Services
Table 22. Medtronic Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Allergan Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Major Business
Table 25. Allergan Drug–Device Combination Products Product and Services
Table 26. Allergan Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 28. Boston Scientific Major Business
Table 29. Boston Scientific Drug–Device Combination Products Product and Services
Table 30. Boston Scientific Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Drug–Device Combination Products Product and Services
Table 34. Novartis Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. BD Basic Information, Manufacturing Base and Competitors
Table 36. BD Major Business
Table 37. BD Drug–Device Combination Products Product and Services
Table 38. BD Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teleflex Incorporated Basic Information, Manufacturing Base and Competitors
Table 40. Teleflex Incorporated Major Business
Table 41. Teleflex Incorporated Drug–Device Combination Products Product and Services
Table 42. Teleflex Incorporated Drug–Device Combination Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drug–Device Combination Products Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drug–Device Combination Products Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drug–Device Combination Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drug–Device Combination Products Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drug–Device Combination Products Production Site of Key Manufacturer
Table 48. Drug–Device Combination Products New Entrant and Capacity Expansion Plans
Table 49. Drug–Device Combination Products Mergers & Acquisitions in the Past Five Years
Table 50. Global Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
Table 51. Global Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
Table 52. Global Drug–Device Combination Products Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drug–Device Combination Products Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 55. Global Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 56. Global Drug–Device Combination Products Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drug–Device Combination Products Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drug–Device Combination Products Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Drug–Device Combination Products Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 61. Global Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 62. Global Drug–Device Combination Products Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drug–Device Combination Products Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drug–Device Combination Products Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Drug–Device Combination Products Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
Table 67. North America Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
Table 68. North America Drug–Device Combination Products Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drug–Device Combination Products Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 71. North America Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 72. North America Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 73. North America Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drug–Device Combination Products Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drug–Device Combination Products Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drug–Device Combination Products Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drug–Device Combination Products Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 90. South America Drug–Device Combination Products Sales by Country (2017-2022) & (K Units)
Table 91. South America Drug–Device Combination Products Sales by Country (2023-2028) & (K Units)
Table 92. South America Drug–Device Combination Products Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drug–Device Combination Products Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 95. South America Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 96. South America Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 97. South America Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drug–Device Combination Products Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drug–Device Combination Products Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drug–Device Combination Products Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drug–Device Combination Products Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drug–Device Combination Products Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drug–Device Combination Products Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drug–Device Combination Products Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drug–Device Combination Products Sales by Application (2023-2028) & (K Units)
Table 106. Drug–Device Combination Products Raw Material
Table 107. Key Manufacturers of Drug–Device Combination Products Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drug–Device Combination Products Typical Distributors
Table 111. Drug–Device Combination Products Typical Customers
List of Figures
Figure 1. Drug–Device Combination Products Picture
Figure 2. Global Drug–Device Combination Products Revenue Market Share by Type in 2021
Figure 3. Infusion Pumps
Figure 4. Orthopedic Combination Products
Figure 5. Photodynamic Therapy Devices
Figure 6. Transdermal Patches
Figure 7. Drug Eluting Stents
Figure 8. Wound Care Products
Figure 9. Inhalers
Figure 10. Other
Figure 11. Global Drug–Device Combination Products Revenue Market Share by Application in 2021
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Other
Figure 15. Global Drug–Device Combination Products Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Drug–Device Combination Products Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Drug–Device Combination Products Sales (2017-2028) & (K Units)
Figure 18. Global Drug–Device Combination Products Price (2017-2028) & (USD/Unit)
Figure 19. Global Drug–Device Combination Products Production Capacity (2017-2028) & (K Units)
Figure 20. Global Drug–Device Combination Products Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Drug–Device Combination Products Market Drivers
Figure 22. Drug–Device Combination Products Market Restraints
Figure 23. Drug–Device Combination Products Market Trends
Figure 24. Global Drug–Device Combination Products Sales Market Share by Manufacturer in 2021
Figure 25. Global Drug–Device Combination Products Revenue Market Share by Manufacturer in 2021
Figure 26. Drug–Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Drug–Device Combination Products Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Drug–Device Combination Products Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 30. Global Drug–Device Combination Products Revenue Market Share by Region (2017-2028)
Figure 31. North America Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 32. Europe Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 34. South America Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Drug–Device Combination Products Revenue (2017-2028) & (USD Million)
Figure 36. Global Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 37. Global Drug–Device Combination Products Revenue Market Share by Type (2017-2028)
Figure 38. Global Drug–Device Combination Products Price by Type (2017-2028) & (USD/Unit)
Figure 39. Global Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 40. Global Drug–Device Combination Products Revenue Market Share by Application (2017-2028)
Figure 41. Global Drug–Device Combination Products Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 43. North America Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 44. North America Drug–Device Combination Products Sales Market Share by Country (2017-2028)
Figure 45. North America Drug–Device Combination Products Revenue Market Share by Country (2017-2028)
Figure 46. United States Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 50. Europe Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 51. Europe Drug–Device Combination Products Sales Market Share by Country (2017-2028)
Figure 52. Europe Drug–Device Combination Products Revenue Market Share by Country (2017-2028)
Figure 53. Germany Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Drug–Device Combination Products Revenue Market Share by Region (2017-2028)
Figure 62. China Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 69. South America Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 70. South America Drug–Device Combination Products Sales Market Share by Country (2017-2028)
Figure 71. South America Drug–Device Combination Products Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Drug–Device Combination Products Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Drug–Device Combination Products Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Drug–Device Combination Products Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Drug–Device Combination Products Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Drug–Device Combination Products Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Drug–Device Combination Products in 2021
Figure 83. Manufacturing Process Analysis of Drug–Device Combination Products
Figure 84. Drug–Device Combination Products Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source

※参考情報 医薬品・装置組み合わせ製品、一般に「ドラッグデバイスコンビネーション製品」と呼ばれるものは、医薬品と医療機器が統合された製品を指します。このような製品は、患者の治療において不可欠な役割を果たしています。従来の単一の医薬品や医療機器では提供できない、より効果的な治療を実現するために設計されています。 まず基本的な定義から始めると、医薬品・装置組み合わせ製品は、特定の医薬品とその薬効を促進するために設計された機器が組み合わさった製品です。例えば、ドラッグデリバリーシステムやインスリンポンプなどが挙げられます。これにより、薬物の投与やその効果の持続、または副作用の軽減が図られることになります。 特徴としては、まず第一に、その複雑な構造が挙げられます。医薬品と装置が一体化されていることで、使用者は通常の投与方法よりも簡便に、かつ正確に薬物を管理することができます。このため、患者のコンプライアンス向上にも寄与することが期待されます。さらに、さまざまな測定機能を組み込むことで、医療従事者が患者の状態をリアルタイムで把握しやすくすることも可能になります。 また、医薬品と機器の相互作用も重要な要素です。医薬品の性質によっては、デバイスの材料や構造がその薬効に影響を与えることがあります。したがって、デバイス設計の段階で、薬剤との相互作用を慎重に検討する必要があります。 種類としては、いくつかの分類が存在します。例えば、薬物を体内に直接投与するための注射器やインプラント、吸入器、あるいは外部から投与される経皮パッチなどが含まれます。また、慢性疾患に対する長期的な治療のためのインスリンポンプや、デジタル機能を持つウェアラブルデバイスも、ドラッグデバイスコンビネーションに含まれることがあります。 用途については、さまざまな疾病治療に応じて多岐にわたります。糖尿病や喘息、心臓疾患、がん治療など、特定のケアが求められる領域でこれらの製品は非常に効果的です。例えば、糖尿病患者の場合、インスリンポンプは血糖値の自己管理をサポートし、医薬品の投与を最適化する役割を担います。喘息患者に対しては、吸入器により迅速に薬物を吸入することができ、発作時の対応をスムーズに行えるように配慮されています。 関連技術に関しては、近年のデジタルヘルスの発展も大きな影響を与えています。特に、スマートフォンやアプリケーションを通じてデバイスを遠隔管理する方法や、IoT技術を利用してリアルタイムでデータを分析することが可能となってきています。これにより、患者が自身の健康状態をモニタリングし、必要に応じたサポートが受けられるようなシステムが構築されています。また、機械学習やビッグデータ解析により、治療法の選択や投与量の最適化なども進められています。 製品開発においては、薬品と医療機器という異なる規制が存在するため、承認プロセスが複雑になることがあります。例えば、医薬品としての治験と、医療機器としての性能評価、両方をクリアしなければならないため、開発期間やコストが増大する可能性があります。このことは、製品が市場に出るまでの時間が長くなる要因にもなりえます。 しかしながら、ドラッグデバイスコンビネーション製品の市場は今後ますます拡大することが期待されています。人口の高齢化や慢性疾患の増加、生活習慣病の普及といった社会的な背景もこの成長を後押ししています。医療の質を向上させるためには、これらの製品がますます重要な役割を担っていくことでしょう。 このように、医薬品・装置組み合わせ製品は、医療現場において非常に重要な意味を持っています。患者のQOL（Quality of Life）を向上させるための新しい手段として、今後の技術革新によりさらに進化していくことが期待されます。政策側でもこの分野への注目が高まっており、研究開発の支援や規制の整備が進むことで、より多くの患者がこれらの技術の恩恵を受けられることが望まれます。 医療従事者と患者がより良い関係を築くためにも、ドラッグデバイスコンビネーション製品の理解を深め、利用促進に向けた取り組みが必要です。今後、さらに高度なソリューションが登場することにより、医療の現場における新たな可能性が開かれることでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer